Final Overall Survival and Other Efficacy and Safety Results From ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged NSCLC

Makoto Nishio, Enriqueta Felip, Sergey Orlov, Keunchil Park, Chong Jen Yu, Chun Ming Tsai, Manuel Cobo, Mark McKeage, Wu Chou Su, Tony Mok, Giorgio V. Scagliotti, David R. Spigel, Kalyanee Viraswami-Appanna, Zhe Chen, Vanessa Q. Passos, Alice T. Shaw

研究成果: Article同行評審

6 引文 斯高帕斯(Scopus)

指紋

深入研究「Final Overall Survival and Other Efficacy and Safety Results From ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged NSCLC」主題。共同形成了獨特的指紋。

Medicine & Life Sciences